Sort
30,917 grants matching “tumor microenvironment”
Investigating and Targeting TAMs in the Glioma Microenvironment
$300,361Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancer
$300,357Shipra Gandhi · Emory University · K08 · FY2025 · CA
ECM Stiffness as a Regulator of Tumor Cell Dissemination and Dormancy
$300,315Patricia J Keely · Albert Einstein College Of Medicine · U54 · FY2013 · CA
Enhancing immune therapy in pancreatic cancer by targeting IL-6
$300,300Gregory B. Lesinski · Emory University · R01 · FY2016 · CA
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
$300,300Ellen Pure' · Wistar Institute · R01 · FY2012 · CA
Leukocyte-Endothelial Adhesion in Tumor Immunity
$300,266Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2013 · CA
Heparanase regulation of tumor host interactions in myeloma and breast cancer
$300,212Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2010 · CA
To Understand/Augment OX40-mediated Tumor Immunotherapy
$300,210Andrew D Weinberg · Providence Portland Medical Center · R01 · FY2007 · CA
Role of myeloid immune suppressors in tumor angiogenesis
$300,200Vanderbilt University · R01 · FY2005 · CA
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis
$300,198Jin Chen · Vanderbilt University · R01 · FY2010 · CA
Molecular Targeted Radionuclide Therapy with Tumor-Specific Vaccine to Stimulate and Expand T-cell Activation
$300,190Douglas G McNeel · University Of Wisconsin-Madison · P01 · FY2024 · CA
Administrative Supplement to UW Carbone Comprehensive Cancer Center Support Grant for the Cancer Center Cessation Initiative (C3I) Coordinating Center
$300,104Howard H Bailey · University Of Wisconsin-Madison · P30 · FY2021 · CA
Identifying mechanisms linking stress biology to human breast cancer
$300,084Suzanne Daniela Conzen · University Of Chicago · R01 · FY2013 · CA
Inflammation and Immunosuppression in Lung Cancer
$300,048Cong Yan · Indiana University Indianapolis · R01 · FY2014 · CA
Unexpected Roles for the alpha2beta1 Integrin
$300,036Vanderbilt University · R01 · FY2005 · CA
VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity
$300,000Michael Rosenzweig · Immunext, Inc. · R43 · FY2012 · AI
Protease Activated Masked Interferon to Treat Malignancy
$300,000David R Stover · Qwixel Therapeutics, Llc · R43 · FY2019 · CA
Improving Chemotherapy with a Novel Oxygen-Delivery Protein
$300,000Ana Krtolica · Omniox, Inc. · R43 · FY2012 · CA
Alterations and Renovation
$300,000Rhonda D Cardin · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM
Cancer Center Support Grant
$300,000Anil K Rustgi · Columbia University Health Sciences · P30 · FY2020 · CA
Targeting galectin-3 to overcome drug resistance in metastatic prostate cancer therapy
$300,000Hafiz Ahmed · Glycomantra, Inc. · R43 · FY2018 · CA
Development of Inhibitors of cANGPTL4 for Pancreatic Cancer Therapeutics
$300,000Aj Singhal · Cfd Research Corporation · R43 · FY2019 · CA
EAGER: A Microfluidic Device for Studying Environment-Triggered Migration of Glioblastoma Cells
$300,000Stefan H Bossmann · Kansas State University · · FY2019 · ENG
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers
$300,000Vishwas Paralkar · Cybrexa, Inc. · R44 · FY2019 · CA
INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC
$300,000Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R43 · FY2017 · CA